Biomanufacturing, Biopharmaceutical, Collaboration, COVID-19, Innovation, Workforce

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

Announcement, Biomanufacturing, Biopharmaceutical, Innovation, Manufacturing

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

Biomanufacturing, Innovation, Materials

The (NIIMBL), a proud member of 91¿´Æ¬Â®, is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and EMD Serono (the U.S. businesses of Merck KGaA, Darmstadt, Germany), among others, to its growing membership base.

These companies join more than 79...